0001579010 false 0001579010 2022-03-08 2022-03-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

  

Date of Report (Date of earliest event reported): March 8, 2022

 

LIFE ON EARTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other
jurisdiction of incorporation)
  000-55464
(Commission
File Number)
  46-2552550
(I.R.S. Employer
Identification No.)

 

1345 6th Ave., 2nd Floor

New York, NY
(Address of principal executive offices)

  10105
(Zip Code)

 

Registrant’s telephone number, including area code: (646) 844-9897

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

     
Title of each class Trading Symbol(s) Name of each exchange on which registered
None    

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company          

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 
 

 

Section 1 - Registrant’s Business and Operations

Item 1.01 Entry into a Material Definitive Agreement

 

On March 8, 2022, we executed a Stock Purchase and Mutual Release Agreement (the “Agreement”). Under the Agreement, we divested our ownership of our former subsidiary SmartAxiom, Inc. (“SA”). The decision was made due to certain critical factors including, but not limited to, 1) the focus of our company towards exclusively the medical technology industry, 2) the slow progress of performance from SA in comparison to the results already underway with the CareClix acquisition, and 3) in order to redeploy resources towards the growth potential of the CareClix group of companies. Under the Agreement, we agreed to transfer all of our equity ownership in SA to Amit Biyani in exchange for Mr. Biyani’s agreement to return to us, for cancellation: (ii) 7,794,695 shares of our common stock; and (ii) 128,822 shares of our Series D Preferred Stock. In addition, SA and Mr. Biyani have agreed to arrange for the return and cancellation of not less than 64,942 shares of our Series D Preferred Stock currently held by other former shareholders of SA. By agreement among the parties, the divestiture of SA will be deemed legally effective as of December 31, 2021. The Agreement also contains mutual releases amongst the parties.

 

Also on March 8, 2021, and in connection with the Agreement, SA issued us an 8% Unsecured Convertible Note in the amount of $250,000 dated February 28, 2022 (the “Note”). The Note bears interest at a rate of 8 percent per year, with all principal and interest due on or before February 28, 2024. All unpaid principal and interest owing under the Note may, at our option, be converted in whole into a number of fully-paid and non-assessable shares of common stock of SA having a value equal to the Note balance converted at an assumed total valuation of SA of $6,250,000 on fully diluted basis.

 

The Agreement and the Note contain numerous additional terms, covenants, and conditions and should be reviewed in their entirety for additional information.

 

Section 9 - Financial Statements and Exhibits Item

9.01 Financial Statements and Exhibits

 

Exhibit No. Description
10.1 Stock Purchase and Mutual Release Agreement
10.2 8% Unsecured Convertible Note

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 Date: March 11, 2022 LIFE ON EARTH, INC.  
   

 

 

 
  By:  /s/ Mahmood Khan  
  Name:  Mahmood Khan  
  Title:  Chief Executive Officer  
       
       

 



Exhibit 10.1

Stock Purchase and Mutual Release Agreement

 

Please refer to the accompanying Exhibit 10.1. It is saved in PDF format.

 



Exhibit 10.2

8% Unsecured Convertible Note

 

Please refer to the accompanying Exhibit 10.2. It is saved in PDF format.

 



v3.22.0.1
Cover
Mar. 08, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 08, 2022
Entity File Number 000-55464
Entity Registrant Name LIFE ON EARTH, INC.
Entity Central Index Key 0001579010
Entity Tax Identification Number 46-2552550
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1345 6th Ave
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10105
City Area Code (646)
Local Phone Number 844-9897
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false


This regulatory filing also includes additional resources:
exhibit_10-1.pdf
exhibit_10-2.pdf
Life on Earth (CE) (USOTC:LFER)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Life on Earth (CE) Charts.
Life on Earth (CE) (USOTC:LFER)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Life on Earth (CE) Charts.